ClinicalTrials.Veeva

Menu

Systemic Redesign and Demonstration for Early Detection, Evaluation and Management of Chronic Kidney Disease in Shanghai (SCREENING)

N

Naval Military Medical University (Second Military Medical University)

Status

Unknown

Conditions

Chronic Kidney Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT03084172
CZKIPLA-CKD-001

Details and patient eligibility

About

Based on clinical evidence based medicine and organizational management model, investigators redesign the prevention and treatment of chronic kidney disease of public health system in Shanghai China. The investigators hope to find early chronic kidney disease, prevention and clinical intervention of orderly combination. The advantages of this system were confirmed by comparing the prevalence rate, awareness rate and treatment rate before and after the completion of the system.

Full description

The whole study mainly includes the following parts:

  1. Establishment of a database of patients with kidney disease, and training data entry specialist in every center.
  2. Conduct propaganda of kidney disease knowledge, training professional doctors in center hospital and community hospital.
  3. Search for high-risk patients, and screening for patients with kidney disease from community residents in community hospital.
  4. Establishment of a standardized and orderly patient referral process from community hospital to center hospital or three level of first-class hospital.

Enrollment

2,000,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Over 18 years of age.
  • Signed informed consent

Exclusion criteria

  • Refused to accept the blood and urine test

Trial design

2,000,000 participants in 1 patient group

chronic kidney disease patients group
Description:
These patients were screened from 2000000 of the population. The investigator will compare the prevalence rate, awareness rate and treatment rate before and after the completion of the system. The degree of decreased glomerular filtration rate is also an important evaluation index.

Trial contacts and locations

34

Loading...

Central trial contact

Yiyi Ma, Doctor; xiao Qin, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems